{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid6gpeioj33k5u55h2gelgx3l7ghievmgcuynajl5zlgx6twgqxoq",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mmcbbrqo5sk2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib77klltitmlngetd5rqeifn5br5rpnulb636gldwsl2uuz5vpnei"
    },
    "mimeType": "image/jpeg",
    "size": 266206
  },
  "path": "/news/2026-05-trial-anti-inflammatory-drug-difficult.html",
  "publishedAt": "2026-05-20T11:00:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomized controlled clinical trial, published in JAMA Psychiatry.",
  "title": "Pilot trial suggests anti-inflammatory drug could help difficult-to-treat depression"
}